Aura Biosciences (AURA) announced the appointment of Teresa Bitetti, President of the Global Oncology Business Unit at Takeda, to the Company’s Board of Directors, effective March 31, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AURA:
- Aura Biosciences Inc: Promising Clinical Progress and Financial Stability Justify Buy Rating
- Aura Biosciences Stock (AURA) Continues to Slide Despite Promising Clinical Progress
- Aura Biosciences price target lowered to $19 from $21 at Citizens JMP
- Aura Biosciences Reports Progress in Cancer Trials
- Aura Biosciences price target raised to $25 from $22 at H.C. Wainwright